Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

EVP, Chief Mktg/Strtgy Officer

Chief Executive Officer

Chief Commercial Officer

Chief Medical Officer

Chief Operating Officer

President & CFO

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladd...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-31	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-31	Premium	sold	Premium	Premium	Premium	EVP, Chief Mktg/Strtgy Officer
2024-01-31	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-01-31	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	EVP, Chief Mktg/Strtgy Officer
2024-01-31	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2024-01-31	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-01-08	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-12-28	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-12-26	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-09-29	Premium	acquired	Premium	Premium	Premium	President & CFO
2023-09-29	Premium	sold	Premium	Premium	Premium	President & CFO
2023-08-15	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-08-08	Premium	gifted	Premium	Premium	Premium	-
2023-07-28	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-
2023-06-26	Premium	acquired	Premium	Premium	Premium	-

AXNX - Axonics Modulation Technologies Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for AXNX